Home/Filings/4/0001415889-25-002981
4//SEC Filing

Peetz Christopher 4

Accession 0001415889-25-002981

CIK 0001759425other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 5:30 PM ET

Size

5.5 KB

Accession

0001415889-25-002981

Insider Transaction Report

Form 4
Period: 2025-02-03
Peetz Christopher
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Sale

    Common Stock

    2025-02-03$48.22/sh9,102$438,921115,920 total
Holdings
  • Common Stock

    (indirect: By Trust)
    208,570
Footnotes (1)
  • [F1]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1
  • filerCIK 0001614740

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:30 PM ET
Size
5.5 KB